Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
Oxidation of low-density lipoprotein (LDL) has a key role in atherogenesis. Among the different models of oxidation that have been studied, the one using myeloperoxidase (MPO) is thought to be more physiopathologically relevant. Apolipoprotein B-100 is the unique protein of LDL and is the major targ...
Main Authors: | Cédric Delporte, Pierre Van Antwerpen, Luc Vanhamme, Thierry Roumeguère, Karim Zouaoui Boudjeltia |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/971579 |
Similar Items
-
Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases
by: Catherine Coremans, et al.
Published: (2021-08-01) -
Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men
by: Karim Zouaoui Boudjeltia, et al.
Published: (2013-01-01) -
Data on myeloperoxidase-oxidized low-density lipoproteins stimulation of cells to induce release of resolvin-D1
by: Damien Dufour, et al.
Published: (2018-06-01) -
Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis.
by: Karim Zouaoui Boudjeltia, et al.
Published: (2012-01-01) -
M2 Monocyte Polarization in Dialyzed Patients Is Associated with Increased Levels of M-CSF and Myeloperoxidase-Associated Oxidative Stress: Preliminary Results
by: Valérie Pireaux, et al.
Published: (2021-01-01)